A carregar...
Combinations using checkpoint blockade to overcome resistance
The advent of immunotherapy for cancer represented a paradigm shift in the treatment approach of neoplasia. Immune-checkpoint inhibitors (ICIs) were demonstrated to significantly improve outcomes, including overall survival across several cancer types, with yearly-durable responses. Nevertheless, ma...
Autores principales: | , |
---|---|
Formato: | Online Artigo Texto |
Idioma: | English |
Publicado em: |
Cancer Intelligence
2020
|
Assuntos: | |
Acesso em linha: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864692/ https://www.ncbi.nlm.nih.gov/pubmed/33574893 http://dx.doi.org/10.3332/ecancer.2020.1148 |